跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEFITELIO defibrotide 200 mg/2.5 mL concentrated solution for infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
DEFITELIO defibrotide 200 mg/2.5 mL concentrated solution for infusion vial
Approved
STANDARD
DEFITELIO defibrotide 200 mg/2.5 mL concentrated solution for infusion vial
Jazz Pharmaceuticals ANZ Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
af8d2cf3a0c0ef89
Company
Jazz Pharmaceuticals ANZ Pty Ltd
Type
Standard
Approval Details
Approval Id
af8d2cf3a0c0ef89
Product Name
DEFITELIO defibrotide 200 mg/2.5 mL concentrated solution for infusion vial
Artg Id
319221
Artg Name
DEFITELIO defibrotide 200 mg/2.5 mL concentrated solution for infusion vial
Sponsor
Jazz Pharmaceuticals ANZ Pty Ltd
Company Detail Path
/organization/jazz-pharmaceuticals-anz-pty-ltd
Artg Date
2020-07-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5e1e7e49c13a83d851f0bfc6df6cd1cd.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/42c3d89853ffd3c27a4d8163ab5e7e98.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
af8d2cf3a0c0ef89
Type
Standard
Back to TGA Approvals